Literature DB >> 22562456

HIF-mediated endothelial response during cancer progression.

Colin E Evans1, Cristina Branco-Price, Randall S Johnson.   

Abstract

Tumour growth at primary or secondary extravasation sites leads to localised regions of reduced oxygen tension (hypoxia) in cells both within and surrounding the tumour. Although the angiogenic response of the tumour cell to hypoxia has been widely examined, the effect of hypoxia on other cell types within the tumour microenvironment is less clear. The endothelium is highly responsive to local hypoxia and regulates tumour cell dissemination and ultimately metastatic success through differential regulation of hypoxia-inducible transcription factors (HIFs). The endothelial response to hypoxia particularly mediates key processes that regulate tumour vascularisation and cancer progression, including proliferation, migration, adherence, and vascular permeability. This article describes current understanding of the HIF-mediated endothelial response to hypoxia during cancer progression. Endothelial HIF signalling regulates tumour growth and metastasis and is therefore an attractive putative target for treatments that inhibit cancer progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562456     DOI: 10.1007/s12185-012-1072-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  75 in total

1.  Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.

Authors:  Jae Hong Im; Weili Fu; Hui Wang; Sujata K Bhatia; Daniel A Hammer; M Anna Kowalska; Ruth J Muschel
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

2.  Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination.

Authors:  Amjad Kanaan; Reza Farahani; Robert M Douglas; Joseph C Lamanna; Gabriel G Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-01       Impact factor: 3.619

3.  Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.

Authors:  D V Faller; H Weng; S Y Choi
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

4.  Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.

Authors:  Nicolas Skuli; Amar J Majmundar; Bryan L Krock; Rickson C Mesquita; Lijoy K Mathew; Zachary L Quinn; Anja Runge; Liping Liu; Meeri N Kim; Jiaming Liang; Steven Schenkel; Arjun G Yodh; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

5.  Hypoxic induction of interleukin-8 gene expression in human endothelial cells.

Authors:  M Karakurum; R Shreeniwas; J Chen; D Pinsky; S D Yan; M Anderson; K Sunouchi; J Major; T Hamilton; K Kuwabara; A Rot; R Nowygrod; D Stern
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 6.  Genetic link between cancer and thrombosis.

Authors:  Carla Boccaccio; Paolo M Comoglio
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

7.  Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells.

Authors:  A Namiki; E Brogi; M Kearney; E A Kim; T Wu; T Couffinhal; L Varticovski; J M Isner
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

8.  JunD reduces tumor angiogenesis by protecting cells from oxidative stress.

Authors:  Damien Gerald; Edurne Berra; Yves M Frapart; Denise A Chan; Amato J Giaccia; Daniel Mansuy; Jacques Pouysségur; Moshe Yaniv; Fatima Mechta-Grigoriou
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

Review 9.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

Authors:  Christian Fischer; Massimiliano Mazzone; Bart Jonckx; Peter Carmeliet
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

10.  Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success.

Authors:  Cristina Branco-Price; Na Zhang; Moritz Schnelle; Colin Evans; Dörthe M Katschinski; Debbie Liao; Lesley Ellies; Randall S Johnson
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

View more
  6 in total

1.  Loss of endothelial-ARNT in adult mice contributes to dampened circulating proangiogenic cells and delayed wound healing.

Authors:  Yu Han; Jiayi Tao; Alla Gomer; Diana L Ramirez-Bergeron
Journal:  Vasc Med       Date:  2014-11-14       Impact factor: 3.239

2.  Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1α in pancreatic cancer: Implications for tumor progression and prognosis.

Authors:  Shi-Kai Zhu; Yu Zhou; Chao Cheng; Shan Zhong; Han-Qing Wu; Bo Wang; Ping Fan; Jiong-Xin Xiong; Hong-Ji Yang; He-Shui Wu
Journal:  Mol Clin Oncol       Date:  2014-07-09

Review 3.  Hypoxia: Signaling the Metastatic Cascade.

Authors:  Erinn B Rankin; Jin-Min Nam; Amato J Giaccia
Journal:  Trends Cancer       Date:  2016-06-02

4.  The close interaction between hypoxia-related proteins and metastasis in pancarcinomas.

Authors:  Andrés López-Cortés; Lavanya Prathap; Esteban Ortiz-Prado; Nikolaos C Kyriakidis; Ángela León Cáceres; Isaac Armendáriz-Castillo; Antonella Vera-Guapi; Verónica Yumiceba; Katherine Simbaña-Rivera; Gabriela Echeverría-Garcés; Jennyfer M García-Cárdenas; Andy Pérez-Villa; Patricia Guevara-Ramírez; Andrea Abad-Sojos; Jhommara Bautista; Lourdes Puig San Andrés; Nelson Varela; Santiago Guerrero
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

5.  Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon.

Authors:  Cristina Branco-Price; Colin E Evans; Randall S Johnson
Journal:  Oncotarget       Date:  2013-12

Review 6.  Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.

Authors:  Nehad M Ayoub; Sara K Jaradat; Kamal M Al-Shami; Amer E Alkhalifa
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.